本页面由Tiger Trade Technology Pte. Ltd.提供服务

Chinook Therapeutics, Inc.

40.39
0.0000
成交量:- -
成交额:- -
市值:29.00亿
市盈率:-11.49
高:40.39
开:40.39
低:40.39
收:40.39
52周最高:40.39
52周最低:40.39
股本:7,180.50万
流通股本:6,038.70万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.5165
每股收益(LYR):-2.9185
净资产收益率:-56.85%
总资产收益率:-26.82%
市净率:8.12
市盈率(LYR):-13.84

数据加载中...

2023/06/13

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/24

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/13

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/03/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/27

重要事件披露

8-K - Current report
2023/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/24

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership